Chemical activators of Nim1 function by modulating intracellular signaling pathways that lead to the protein's activation. Forskolin is a well-known activator of adenylate cyclase, which catalyzes the conversion of ATP to cyclic AMP (cAMP). The increase in cAMP levels results in the activation of protein kinase A (PKA), a key kinase that can phosphorylate and thereby activate Nim1. Similarly, 8-Bromo-cAMP, a cAMP analog, can permeate cell membranes and directly activate PKA, which in turn phosphorylates and activates Nim1. Isoproterenol, a beta-adrenergic agonist, enhances cAMP production by stimulating adenylate cyclase via the beta-adrenergic receptor, leading to PKA activation and subsequent Nim1 phosphorylation and activation.
Rolipram and IBMX act as phosphodiesterase inhibitors, preventing the breakdown of cAMP and thereby sustaining an elevated level of this messenger molecule within the cell. This persistence of cAMP prolongs the activation state of PKA, which then consistently activates Nim1. Prostaglandin E1 (PGE1) and Epinephrine, through interaction with their respective receptors, also raise cAMP levels. PGE1 binds to its receptor leading to adenylate cyclase activation, whereas epinephrine interacts with beta-adrenergic receptors achieving the same effect. Both routes culminate in the PKA-mediated activation of Nim1. Glucagon, by binding to its specific receptor, and Terbutaline and Salbutamol, by activating beta2-adrenergic receptors, all enhance cAMP levels, enabling PKA activation and in turn, the activation of Nim1.
Dibutyryl-cAMP, another cell-permeable analog of cAMP, directly activates PKA, bypassing the receptor-mediated steps and leading to Nim1 activation. Lastly, Anagrelide inhibits phosphodiesterase III, resulting in increased cAMP and PKA activation. The common thread among these chemical activators is their ability to raise intracellular cAMP levels, either by promoting its production, mimicking its action, or inhibiting its degradation, which leads to the activation of PKA and the subsequent activation of Nim1 through phosphorylation. This cascade of events highlights the pivotal role of cAMP and PKA in the regulation and activation of Nim1, underscoring the importance of these signaling molecules in cellular processes.
関連項目
产品名称 | CAS # | 产品编号 | 数量 | 价格 | 应用 | 排名 |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
蕨麻可直接提高 cAMP 水平,而 cAMP 可通过促进蛋白激酶 A(PKA)的活化来激活 Nim1,PKA 可使 Nim1 磷酸化,从而激活 Nim1。 | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $106.00 $166.00 $289.00 $550.00 $819.00 | 2 | |
8-Bromo-cAMP 是一种细胞渗透性 cAMP 类似物,可激活 PKA,导致 Nim1 的磷酸化和活化。 | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
罗利普仑可抑制磷酸二酯酶-4,阻止 cAMP 降解,从而促进 PKA 激活和随后的 Nim1 激活。 | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
IBMX 是一种非选择性磷酸二酯酶抑制剂,可防止 cAMP 分解,增加 PKA 活性,从而可能导致 Nim1 激活。 | ||||||
PGE1 (Prostaglandin E1) | 745-65-3 | sc-201223 sc-201223A | 1 mg 10 mg | $30.00 $142.00 | 16 | |
前列腺素 E1 (PGE1) 可提高 cAMP 水平,激活 PKA,进而使 Nim1 磷酸化并激活。 | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $40.00 $102.00 $197.00 $1739.00 $16325.00 | ||
肾上腺素能与β-肾上腺素能受体相互作用,提高 cAMP 水平并激活 PKA,从而激活 Nim1。 | ||||||
Terbutaline Hemisulfate | 23031-32-5 | sc-204911 sc-204911A | 1 g 5 g | $90.00 $371.00 | 2 | |
特布他林是β2-肾上腺素能受体激动剂,可提高 cAMP 水平,激活 PKA,从而可能导致 Nim1 的激活。 | ||||||
Salbutamol | 18559-94-9 | sc-253527 sc-253527A | 25 mg 50 mg | $92.00 $138.00 | ||
沙丁胺醇会激活 beta2 肾上腺素能受体,导致 cAMP 增加和 PKA 激活,从而激活 Nim1。 | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
二丁烯酰-cAMP 是另一种细胞渗透性 cAMP 类似物,可激活 PKA,从而可能激活 Nim1。 |